Jeovanis Gil

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Biology Cancer Biology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (21)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Collaborators (13)

Karolina Pircs

Lund University

SWEDEN

View details

Henriett Kovacsne Oskolas

Lund University

SWEDEN

View details

Romina Vuono

Lecturer in Biological Sciences-Neurosciences/PhD

University of Kent

UNITED KINGDOM

View details

Attila Marcell Szasz

Semmelweis University

HUNGARY

View details

Klaus Griewank

GERMANY

View details

Vivien Horvath

Lund University

SWEDEN

View details

Magdalena Kuras

Lund University

SWEDEN

View details

Indira Pla

Lund University

SWEDEN

View details

Krzysztof Pawłowski

University of Texas Southwestern Medical Center

UNITED STATES

View details

Melinda Rezeli

SWEDEN

View details

Elisabeth Livingstone

University Hospital Essen

GERMANY

View details

Johan Jakobsson

Lund University

SWEDEN

View details

Clemens Aigner

Professor of Thoracic Surgery

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeovanis Gil

Research Interests

Explore related searches

Contact this professor

Articles (21)

Unbiased Drug Target Prediction Reveals Sensitivity to Ferroptosis Inducers, HDAC and RTK Inhibitors in Melanoma Subtypes

Proteogenomic Profiling of Treatment-Naïve Metastatic Malignant Melanoma

Mitochondrial proteome landscape unveils key insights into melanoma severity and treatment strategies

TMEM160 Promotes Tumor Growth in Lung Adenocarcinoma and Cervical Adenocarcinoma Cell Lines

Machine Learning-enhanced X-ray-based Radiomics in the Identification of Post-COVID Patients

Melanoma Proteomics Unveiled

Mitochondrial dysfunction and immune suppression in BRAF V600E‐mutated metastatic melanoma

Identification of genetic fingerprint of type I interferon therapy in visceral metastases of melanoma.

Predicting immune checkpoint therapy response in three independent metastatic melanoma cohorts.

Dynamics of Mitochondrial Proteome and Acetylome in Glioblastoma Cells with Contrasting Metabolic Phenotypes

Mitochondrial and immune response dysregulation in melanoma recurrence

Human iPSC-Derived Hippocampal Spheroids: An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies.

Distinct subcellular autophagy impairments in induced neurons from patients with Huntington's disease

The Prognostic Relevance of PMCA4 Expression in Melanoma: Gender Specificity and Implications for Immune Checkpoint Inhibition

<i>Rhizobium etli</i> CFN42 proteomes showed isoenzymes in free-living and symbiosis with a different transcriptional regulation inferred from a transcriptional regulatory network.

Prediction of early-stage melanoma recurrence using clinical and histopathologic features.

Lipid metabolic reprogramming extends beyond histological tumor demarcations in operable human pancreatic cancer.

Quantitative Proteomic Analysis of Cervical Cancer Tissues Identifies Proteins Associated With Cancer Progression.

Lysine Acetylation Stoichiometry Analysis at the Proteome Level.

Deep Proteomic Analysis on Biobanked Paraffine-Archived Melanoma with Prognostic/Predictive Biomarker Read-Out.

An Observational Study on the Molecular Profiling of Primary Melanomas Reveals a Progression Dependence on Mitochondrial Activation

Collaborators (13)

Karolina Pircs

Henriett Kovacsne Oskolas

Romina Vuono

Attila Marcell Szasz

Klaus Griewank

Vivien Horvath

Magdalena Kuras

Indira Pla

Krzysztof Pawłowski

Melinda Rezeli

Elisabeth Livingstone

Johan Jakobsson

Clemens Aigner

Make your next move.